跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GENRX MOMETASONE NASAL SPRAY mometasone furoate 50 microgram/actuation suspension bottle - TGA Drug Approval Details
Approvals
/
TGA
/
GENRX MOMETASONE NASAL SPRAY mometasone furoate 50 microgram/actuation suspension bottle
Approved
STANDARD
GENRX MOMETASONE NASAL SPRAY mometasone furoate 50 microgram/actuation suspension bottle
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
681d056c9ed6a05b
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
681d056c9ed6a05b
Product Name
GENRX MOMETASONE NASAL SPRAY mometasone furoate 50 microgram/actuation suspension bottle
Artg Id
184660
Artg Name
GENRX MOMETASONE NASAL SPRAY mometasone furoate 50 microgram/actuation suspension bottle
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2012-06-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
681d056c9ed6a05b
Type
Standard
Back to TGA Approvals
